ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

ImClone Protocol Generates More Questions Than Answers.

February 15, 2002

NCI Plans Two New RFAs For Stimulus Funds

March 6, 2009

GSK HPV Vaccine Offers Protection From 4 HPV Types

April 27, 2007

GSK Vaccine Prevents Lesions Associated With HPV

July 28, 2006

Wider Use Of Adjuvant Chemotherapy Recommended By NIH Consensus Panel.

November 10, 2000

Cancer Control Emphasis Shift to Prevention Projected For Y 1978; Advisors Seek More

July 29, 1977